Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 626.30
+8.00 (1.29%)
Mar 13, 2026, 1:44 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 16.4 million as of March 13, 2026. Its market cap has decreased by -72.61% in one year.
Market Cap
16.40M
Enterprise Value
-5.05M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
626.30
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 16.40M, a decrease of -76.41%. That is a compound annual growth rate of -7.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 16.40M | -79.12% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 498.70M |
| Geffen Residence & Renewal | 263.65M |
| Matricelf | 142.71M |
| Clal Biotechnology Industries | 44.86M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 29.14M |
| Evogene | 20.51M |
| XTL Biopharmaceuticals | 19.87M |